OptimizeRx Corporation (OTCMKTS:OPRX) Files An 8-K Results of Operations and Financial Condition
Item 2.02
|
Results of Operations and Financial Condition. |
On May 3, 2017, we issued a press release announcing the results
of operations for the three months ended March 31, 2017.
The press release is furnished with this Current Report on Form
8-K as Exhibit 99.1. The information furnished under this Item
2.02 and Item 9.01 of this Current Report on Form 8-K, including
Exhibit 99.1, shall not be deemed to be filed for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or
otherwise subject to the liabilities of that section, nor shall
it be deemed incorporated by reference in any registration
statement or other filing under the Securities Act of 1933, as
amended, regardless of any general incorporation by reference
language in such filing, except as shall be expressly set forth
by specific reference in any such filing.
SECTION 9 Financial Statements and Exhibits
| Item 9.01 | Financial Statements and Exhibits. |
| ExhibitNo. | Description | |
| 99.1 | Press release, dated May 3, 2017 |
About OptimizeRx Corporation (OTCMKTS:OPRX)
OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products. It provides healthcare providers a means to provide sampling and coupons without having to physically store samples on site. The Company’s principal products and applications include SampleMD, OPTIMIZEHR and OPTIMIZERx.com. SampleMD is a virtual Patient Support Center. OPTIMIZEHR is a consulting practice focused on educating and working with pharmaceutical manufacturers on identifying, formulating and implementing new electronic prescribing (eRx) media strategies for promoting their products. OPTIMIZERx.com is a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs. OptimizeRx Corporation (OTCMKTS:OPRX) Recent Trading Information
OptimizeRx Corporation (OTCMKTS:OPRX) closed its last trading session 00.000 at 0.750 with 2,500 shares trading hands.